ES2056851T3 - Preparacion de terfenadina polimorficamente pura. - Google Patents

Preparacion de terfenadina polimorficamente pura.

Info

Publication number
ES2056851T3
ES2056851T3 ES88106898T ES88106898T ES2056851T3 ES 2056851 T3 ES2056851 T3 ES 2056851T3 ES 88106898 T ES88106898 T ES 88106898T ES 88106898 T ES88106898 T ES 88106898T ES 2056851 T3 ES2056851 T3 ES 2056851T3
Authority
ES
Spain
Prior art keywords
preparation
polymorphically pure
terfenadine
pure terfenadine
polymorphically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88106898T
Other languages
English (en)
Inventor
Timothy G Fawcett
Christian T Goralski
David W Ziettlow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8198929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2056851(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2056851T3 publication Critical patent/ES2056851T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

TETRAFENADINA POLIMORFICAMENTE PURA, 1-(P-TETRA-BUTIFENIL)-4-[4-((ALFA)HIDROXIDIFENILMETIL)-1-PIPERIDINIL]BUTANOL, SE PREPARA POR METODOS DE RECRISTALIZACION SEGURAMENTE CONTROLADOS.
ES88106898T 1988-04-29 1988-04-29 Preparacion de terfenadina polimorficamente pura. Expired - Lifetime ES2056851T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88106898A EP0339118B1 (en) 1988-04-29 1988-04-29 Preparation of polymorphically pure terfenadine

Publications (1)

Publication Number Publication Date
ES2056851T3 true ES2056851T3 (es) 1994-10-16

Family

ID=8198929

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88106898T Expired - Lifetime ES2056851T3 (es) 1988-04-29 1988-04-29 Preparacion de terfenadina polimorficamente pura.

Country Status (8)

Country Link
US (1) US4742175A (es)
EP (1) EP0339118B1 (es)
AR (1) AR243612A1 (es)
AT (1) ATE107283T1 (es)
CA (1) CA1312610C (es)
DE (1) DE3850244T2 (es)
DK (1) DK173555B1 (es)
ES (1) ES2056851T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
IT1217837B (it) * 1988-06-17 1990-03-30 Lepetit Spa Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
ZA901360B (en) * 1989-02-28 1990-11-28 Merrell Dow Pharma Preparation of the low-melting polymorphic form of terfenadine
CA2015390A1 (en) * 1989-05-01 1990-11-01 Frederick J. Mccarty Process for the preparation of the high melting polymorphic of terfenadine
US5247092A (en) * 1989-12-29 1993-09-21 Erregierre Industria Chimica S.P.A. Preparation of the high-melting polymorph of terfenadine
FR2681861B1 (fr) * 1991-10-01 1995-06-09 Isochem Sa Procede de preparation d'une forme polymorphique de la terfenadine, a point de fusion eleve, d'une plus grande purete et produit obtenu.
US5347006A (en) * 1992-12-31 1994-09-13 Augusto Lavacchielli Method of preparing a polymorph of terfenadine
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
HU226559B1 (en) * 1993-06-24 2009-03-30 Amr Technology Process for the production of piperidine derivatives
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
EP1953142A1 (en) 1993-06-25 2008-08-06 Aventis Inc. Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
IT1270829B (it) * 1993-09-17 1997-05-13 Recordati Chem Pharm Procedimento per la preparazione di polimorfo i della terfenadina con distribuzione granulometrica ottimale
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2449419C (en) * 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA728544B (en) * 1972-01-28 1974-02-27 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine

Also Published As

Publication number Publication date
DK210888D0 (da) 1988-04-18
AR243612A1 (es) 1993-08-31
DE3850244T2 (de) 1994-10-06
EP0339118B1 (en) 1994-06-15
DE3850244D1 (de) 1994-07-21
DK173555B1 (da) 2001-03-12
CA1312610C (en) 1993-01-12
US4742175A (en) 1988-05-03
EP0339118A1 (en) 1989-11-02
DK210888A (da) 1989-10-19
ATE107283T1 (de) 1994-07-15

Similar Documents

Publication Publication Date Title
DK104292D0 (da) Heterocycliske forbindelser og fremgangsmaade til deres fremstilling
DE3687206D1 (de) Herzschrittmacher.
NO164093C (no) Pyridinoksyd-mellomprodukter og fremgangsmaate for deres fremstilling.
NO911696L (no) Polypeptider.
DE68913054D1 (de) Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation.
DK339184A (da) Imidazoliumforbindelser, mellemprodukter hertil og fremgangsmaade til deres anvendelse
ES427728A1 (es) Procedimiento para la obtencion de imidazolil-o, n-acetales.
EP0627241A3 (en) Voltage regulator for pacemakers.
ATE107283T1 (de) Herstellung von polymorphisch reinem terfenadine.
ATE46146T1 (de) Phenylpiperidinderivat und seine salze, ihre herstellung, sie enthaltende zusammensetzungen und ihre therapeutische verwendung.
GR3029334T3 (en) Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
ES2047033T3 (es) Un metodo para preparar compuestos de hidroxivitamina d.
ATE154388T1 (de) Verwendung von modifiziertem heparin kofaktor ii
ES481633A1 (es) Un procedimiento de preparacion de derivados de 4-fenil-2- tiazolil-oxamato.
DE69209701D1 (de) Herstellung substituierter Tetrahydropyridine
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
AU5902690A (en) Novel 3-methoximinopropionic esters and fungicides containing them
DE68914992D1 (de) Herstellung von durch nitratoalkyl substituierten cyclischen äthern.
UA19151A (uk) Спосіб одержаhhя оптичhо активhого (+)-4-деметоксидауhоміциhоhу
ATE92318T1 (de) Isolierung von castanospermin und dessen verwendung als antidiabetisches heilmittel.
DK0499489T3 (da) Polyhydroxycyklopentanderivater, deres fremstilling og deres terapeutiske anvendelse
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
DK82787D0 (da) Triazolderivat og fremgangsmaade til fremstilling deraf samt plantevaekstregulerende middel indeholdende derivatet og derivatets anvendelse
NO832046L (no) Mikroorganismestammen chromobacterium violaceum, farmasoeytisk aktive forbindelser fremstilt av stammen, fremgangsmaate til fremstilling av forbindelsene og deres anvendelse som legemiddel
ES2051792T3 (es) Proceso para preparar alfa-(alquilfenil)-4-(hidroxidifenilmetil)-1-piperidina butanol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 339118

Country of ref document: ES